Streetbeat News

Regulatory

LKCO

Luokung Technology Corp. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange. This development is crucial for maintaining investor confidence and access to capital markets.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:30 pm

BTCUSD

ETHUSD

Mark Cuban criticizes SEC Chair Gary Gensler for complex crypto regulations, suggesting a simpler approach like Japan's could have prevented collapses like FTX. Cuban argues current policies hinder crypto growth and supports pro-crypto figures like John Deaton.

Portfolio Pulse from Pooja Rajkumari

October 07, 2024 | 12:30 pm

SPY

A report by the Committee for a Responsible Federal Budget indicates that Trump's proposals could increase US debt by $7.5 trillion, while Harris' could add $3.5 trillion by 2035. Both candidates lack plans to address the debt crisis. The SPDR S&P 500 ETF Trust (SPY) fell 0.45% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

October 07, 2024 | 12:21 pm

RARE

Ultragenyx has received FDA Breakthrough Therapy Designation for Setrusumab (UX143) aimed at reducing fracture risk in patients with Osteogenesis Imperfecta Types I, III, and IV, aged 2 and older.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:08 pm

MNPR

Monopar Therapeutics has initiated a Phase 1a clinical trial for its novel uPAR-targeted radiopharmaceutical therapy aimed at treating advanced cancers. This marks a significant step in the development of new cancer treatments.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:05 pm

BTCUSD

Anthony Scaramucci, founder of SkyBridge Capital, is actively involved in shaping U.S. crypto policy. He praises Trump's shift towards Bitcoin and works with Kamala Harris's team to promote crypto-friendly policies within the Democratic Party. Scaramucci emphasizes the need for bipartisan regulation and criticizes SEC Chair Gary Gensler's approach.

Portfolio Pulse from Murtuza Merchant

October 07, 2024 | 11:57 am

BABA

IVW

NVDA

XLK

Nvidia's GPU sales in China are at risk as the country pushes for domestic AI chips in response to US semiconductor sanctions. This could impact Nvidia's revenue from its H20 GPUs, a significant market for the company. Despite this, analysts remain optimistic about Nvidia's stock potential.

Portfolio Pulse from Anusuya Lahiri

October 07, 2024 | 11:52 am

TRVN

Trevena shares are declining following a Nasdaq delisting notification, indicating potential challenges for the company.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:52 am

NTLA

Intellia Therapeutics has started the HAELO Phase 3 study for NTLA-2002, a single-dose treatment for hereditary angioedema. This marks Intellia's second in vivo candidate to reach late-stage clinical development.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:35 am

OKUR

Trading for a company has been halted at 7:20:34 a.m. ET due to pending news. This indicates that significant information is expected to be released, which could impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:20 am